deltatrials
Completed PHASE1 INTERVENTIONAL 2-arm NCT04426474

A Study of LY3502970 in Participants With Type 2 Diabetes

A Multiple-Dose Study in Participants With Type 2 Diabetes Mellitus to Investigate the Safety, Tolerability, Pharmacokinetics,and Pharmacodynamics of LY3502970

Sponsor: Eli Lilly and Company

Conditions Diabetes Mellitus, Type 2
Interventions LY3502970 Placebo
Updated 13 times since 2020 Last updated: Jul 26, 2021 Started: Oct 8, 2020 Primary completion: Jul 12, 2021 Completion: Jul 12, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Diabetes Mellitus, Type 2, this trial is completed. The trial is conducted by Eli Lilly and Company and has accumulated 13 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Sep 2021 — Jul 2024 [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

  4. May 2021 — Sep 2021 [monthly]

    Recruiting PHASE1

  5. Apr 2021 — May 2021 [monthly]

    Recruiting PHASE1

▶ Show 8 earlier versions

  1. Mar 2021 — Apr 2021 [monthly]

    Recruiting PHASE1

  2. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE1

  3. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  4. Nov 2020 — Dec 2020 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  5. Oct 2020 — Nov 2020 [monthly]

    Not Yet Recruiting PHASE1

  6. Sep 2020 — Oct 2020 [monthly]

    Not Yet Recruiting PHASE1

  7. Aug 2020 — Sep 2020 [monthly]

    Not Yet Recruiting PHASE1

  8. Jul 2020 — Aug 2020 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eli Lilly and Company
Data source: Eli Lilly and Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations